Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 217 to 227 of 227 entries
Sorted by: Best Match Show Resources per page
PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors.

Tumori

Minari R, Bonatti F, Mazzaschi G, Dodi A, Facchinetti F, Gelsomino F, Cinquegrani G, Squadrilli A, Bordi P, Buti S, Bersanelli M, Leonetti A, Cosenza A, Ferri L, Rapacchi E, Quaini F, Ardizzoni A, Tiseo M.
PMID: 34002648
Tumori. 2021 May 18;3008916211014954. doi: 10.1177/03008916211014954. Epub 2021 May 18.

No abstract available.

Cite
Minari R, Bonatti F, Mazzaschi G, et al. PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors. Tumori. 2021;3008916211014954doi: 10.1177/03008916211014954.
Minari, R., Bonatti, F., Mazzaschi, G., Dodi, A., Facchinetti, F., Gelsomino, F., Cinquegrani, G., Squadrilli, A., Bordi, P., Buti, S., Bersanelli, M., Leonetti, A., Cosenza, A., Ferri, L., Rapacchi, E., Quaini, F., Ardizzoni, A., & Tiseo, M. (2021). PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors. Tumori, 3008916211014954. https://doi.org/10.1177/03008916211014954
Minari, Roberta, et al. "PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors." Tumori vol. (2021): 3008916211014954. doi: https://doi.org/10.1177/03008916211014954
Minari R, Bonatti F, Mazzaschi G, Dodi A, Facchinetti F, Gelsomino F, Cinquegrani G, Squadrilli A, Bordi P, Buti S, Bersanelli M, Leonetti A, Cosenza A, Ferri L, Rapacchi E, Quaini F, Ardizzoni A, Tiseo M. PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors. Tumori. 2021 May 18;3008916211014954. doi: 10.1177/03008916211014954. Epub 2021 May 18. PMID: 34002648.
Copy Download .nbib Format: NLM
P.121: The Optimal Cell Packing Density for Macroencapsulating Islet Delivery Devices.

Transplantation

de Vries R, Barzegari M, Carlier A, Geris L, van Apeldoorn A.
PMID: 34908367
Transplantation. 2021 Dec 01;105(12):S45-S46. doi: 10.1097/01.tp.0000804560.86378.96.

No abstract available.

Cite
de Vries R, Barzegari M, Carlier A, et al. P.121: The Optimal Cell Packing Density for Macroencapsulating Islet Delivery Devices. Transplantation. 2021;105(12):S45-S46doi: 10.1097/01.tp.0000804560.86378.96.
de Vries, R., Barzegari, M., Carlier, A., Geris, L., & van Apeldoorn, A. (2021). P.121: The Optimal Cell Packing Density for Macroencapsulating Islet Delivery Devices. Transplantation, 105(12), S45-S46. https://doi.org/10.1097/01.tp.0000804560.86378.96
de Vries, Rick, et al. "P.121: The Optimal Cell Packing Density for Macroencapsulating Islet Delivery Devices." Transplantation vol. 105,12 (2021): S45-S46. doi: https://doi.org/10.1097/01.tp.0000804560.86378.96
de Vries R, Barzegari M, Carlier A, Geris L, van Apeldoorn A. P.121: The Optimal Cell Packing Density for Macroencapsulating Islet Delivery Devices. Transplantation. 2021 Dec 01;105(12):S45-S46. doi: 10.1097/01.tp.0000804560.86378.96. PMID: 34908367.
Copy Download .nbib Format: NLM
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients.

Clinical chemistry and laboratory medicine

Malvagia S, Ferri L, Della Bona M, Borsini W, Cirami CL, Dervishi E, Feriozzi S, Gasperini S, Motta S, Mignani R, Trezzi B, Pieruzzi F, Morrone A, Daniotti M, Donati MA, la Marca G.
PMID: 33915609
Clin Chem Lab Med. 2021 Apr 30;59(9):1516-1526. doi: 10.1515/cclm-2021-0316. Print 2021 Aug 26.

OBJECTIVES: Fabry disease (FD) is an X-linked lysosomal storage disorder, resulting from a deficiency of the enzyme α-galactosidase A, responsible for breaking down glycolipids such as globotriaosylceramide and its deacylated derivative, globotriaosylsphingosine (LysoGb3). Here, we compare the levels of...

Cite
Malvagia S, Ferri L, Della Bona M, et al. Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients. Clin Chem Lab Med. 2021;59(9):1516-1526doi: 10.1515/cclm-2021-0316.
Malvagia, S., Ferri, L., Della Bona, M., Borsini, W., Cirami, C. L., Dervishi, E., Feriozzi, S., Gasperini, S., Motta, S., Mignani, R., Trezzi, B., Pieruzzi, F., Morrone, A., Daniotti, M., Donati, M. A., & la Marca, G. (2021). Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients. Clinical chemistry and laboratory medicine, 59(9), 1516-1526. https://doi.org/10.1515/cclm-2021-0316
Malvagia, Sabrina, et al. "Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients." Clinical chemistry and laboratory medicine vol. 59,9 (2021): 1516-1526. doi: https://doi.org/10.1515/cclm-2021-0316
Malvagia S, Ferri L, Della Bona M, Borsini W, Cirami CL, Dervishi E, Feriozzi S, Gasperini S, Motta S, Mignani R, Trezzi B, Pieruzzi F, Morrone A, Daniotti M, Donati MA, la Marca G. Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients. Clin Chem Lab Med. 2021 Apr 30;59(9):1516-1526. doi: 10.1515/cclm-2021-0316. Print 2021 Aug 26. PMID: 33915609.
Copy Download .nbib Format: NLM
Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia.

Frontiers in psychiatry

Peris L, Szerman N.
PMID: 34975572
Front Psychiatry. 2021 Dec 16;12:769623. doi: 10.3389/fpsyt.2021.769623. eCollection 2021.

Dual disorder is a term applied to patients with an addictive disorder and other mental disorder. Epidemiological studies have established that dual disorders are an expectation rather than an exception. They are difficult to diagnose and treat and constitute...

Cite
Peris L, Szerman N. Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia. Front Psychiatry. 2021;12:769623doi: 10.3389/fpsyt.2021.769623.
Peris, L., & Szerman, N. (2021). Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia. Frontiers in psychiatry, 12769623. https://doi.org/10.3389/fpsyt.2021.769623
Peris, Lola, and Szerman, Nestor. "Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia." Frontiers in psychiatry vol. 12 (2021): 769623. doi: https://doi.org/10.3389/fpsyt.2021.769623
Peris L, Szerman N. Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia. Front Psychiatry. 2021 Dec 16;12:769623. doi: 10.3389/fpsyt.2021.769623. eCollection 2021. PMID: 34975572; PMCID: PMC8716462.
Copy Download .nbib Format: NLM
Towards .

Frontiers in bioengineering and biotechnology

Lafuente-Gracia L, Borgiani E, Nasello G, Geris L.
PMID: 34660547
Front Bioeng Biotechnol. 2021 Sep 30;9:703725. doi: 10.3389/fbioe.2021.703725. eCollection 2021.

No abstract available.

Cite
Lafuente-Gracia L, Borgiani E, Nasello G, et al. Towards . Front Bioeng Biotechnol. 2021;9:703725doi: 10.3389/fbioe.2021.703725.
Lafuente-Gracia, L., Borgiani, E., Nasello, G., & Geris, L. (2021). Towards . Frontiers in bioengineering and biotechnology, 9703725. https://doi.org/10.3389/fbioe.2021.703725
Lafuente-Gracia, Laura, et al. "Towards ." Frontiers in bioengineering and biotechnology vol. 9 (2021): 703725. doi: https://doi.org/10.3389/fbioe.2021.703725
Lafuente-Gracia L, Borgiani E, Nasello G, Geris L. Towards . Front Bioeng Biotechnol. 2021 Sep 30;9:703725. doi: 10.3389/fbioe.2021.703725. eCollection 2021. PMID: 34660547; PMCID: PMC8514728.
Copy Download .nbib Format: NLM
Video calls during the COVID-19 pandemic: A bridge for patients, families, and respiratory therapists.

Families, systems & health : the journal of collaborative family healthcare

Maffoni M, Torlaschi V, Pierobon A, Zanatta F, Grasso R, Bagliani S, Govoni L, Biglieri M, Cerri L, Geraci L, Salvaneschi G, Piaggi G.
PMID: 34723568
Fam Syst Health. 2021 Nov 01; doi: 10.1037/fsh0000661. Epub 2021 Nov 01.

BACKGROUND: In response to COVID-19 pandemic outbreak, healthcare procedures and modalities have changed considerably. Video calls may supply valid support for health care professionals, contributing to maintaining the communication between hospitalized patients and their families. The present study aimed...

Cite
Maffoni M, Torlaschi V, Pierobon A, et al. Video calls during the COVID-19 pandemic: A bridge for patients, families, and respiratory therapists. Fam Syst Health. 2021;doi: 10.1037/fsh0000661.
Maffoni, M., Torlaschi, V., Pierobon, A., Zanatta, F., Grasso, R., Bagliani, S., Govoni, L., Biglieri, M., Cerri, L., Geraci, L., Salvaneschi, G., & Piaggi, G. (2021). Video calls during the COVID-19 pandemic: A bridge for patients, families, and respiratory therapists. Families, systems & health : the journal of collaborative family healthcare, . https://doi.org/10.1037/fsh0000661
Maffoni, Marina, et al. "Video calls during the COVID-19 pandemic: A bridge for patients, families, and respiratory therapists." Families, systems & health : the journal of collaborative family healthcare vol. (2021). doi: https://doi.org/10.1037/fsh0000661
Maffoni M, Torlaschi V, Pierobon A, Zanatta F, Grasso R, Bagliani S, Govoni L, Biglieri M, Cerri L, Geraci L, Salvaneschi G, Piaggi G. Video calls during the COVID-19 pandemic: A bridge for patients, families, and respiratory therapists. Fam Syst Health. 2021 Nov 01; doi: 10.1037/fsh0000661. Epub 2021 Nov 01. PMID: 34723568.
Copy Download .nbib Format: NLM
Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature.

Cancers

Verzè M, Minari R, Gnetti L, Bordi P, Leonetti A, Cosenza A, Ferri L, Majori M, De Filippo M, Buti S, Gasparro D, Nizzoli R, Azzoni C, Bottarelli L, Squadrilli A, Mozzoni P, Tiseo M.
PMID: 34771566
Cancers (Basel). 2021 Oct 28;13(21). doi: 10.3390/cancers13215403.

In order to study alternatives at the tissue biopsy to study EGFR status in NSCLC patients, we evaluated three different liquid biopsy platforms (plasma, urine and exhaled breath condensate, EBC). We also reviewed the literature of the cfDNA biological...

Cite
Verzè M, Minari R, Gnetti L, et al. Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature. Cancers (Basel). 2021;13(21)doi: 10.3390/cancers13215403.
Verzè, M., Minari, R., Gnetti, L., Bordi, P., Leonetti, A., Cosenza, A., Ferri, L., Majori, M., De Filippo, M., Buti, S., Gasparro, D., Nizzoli, R., Azzoni, C., Bottarelli, L., Squadrilli, A., Mozzoni, P., & Tiseo, M. (2021). Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature. Cancers, 13(21), . https://doi.org/10.3390/cancers13215403
Verzè, Michela, et al. "Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature." Cancers vol. 13,21 (2021). doi: https://doi.org/10.3390/cancers13215403
Verzè M, Minari R, Gnetti L, Bordi P, Leonetti A, Cosenza A, Ferri L, Majori M, De Filippo M, Buti S, Gasparro D, Nizzoli R, Azzoni C, Bottarelli L, Squadrilli A, Mozzoni P, Tiseo M. Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature. Cancers (Basel). 2021 Oct 28;13(21). doi: 10.3390/cancers13215403. PMID: 34771566; PMCID: PMC8582482.
Copy Download .nbib Format: NLM
Eating behaviour, physical activity and lifestyle of Italian children during lockdown for COVID-19.

International journal of food sciences and nutrition

Censi L, Ruggeri S, Galfo M, Buonocore P, Roccaldo R.
PMID: 33975495
Int J Food Sci Nutr. 2022 Feb;73(1):93-105. doi: 10.1080/09637486.2021.1921127. Epub 2021 May 12.

In March 2020 Italy went into lockdown due to COVID-19 pandemic and children changed rapidly their lifestyles with possible negative effects on their health status. An online survey collected data on eating habits, physical activity, perception/behaviour of 1027 Italian...

Cite
Censi L, Ruggeri S, Galfo M, et al. Eating behaviour, physical activity and lifestyle of Italian children during lockdown for COVID-19. Int J Food Sci Nutr. 2021;73(1):93-105doi: 10.1080/09637486.2021.1921127.
Censi, L., Ruggeri, S., Galfo, M., Buonocore, P., & Roccaldo, R. (2022). Eating behaviour, physical activity and lifestyle of Italian children during lockdown for COVID-19. International journal of food sciences and nutrition, 73(1), 93-105. https://doi.org/10.1080/09637486.2021.1921127
Censi, Laura, et al. "Eating behaviour, physical activity and lifestyle of Italian children during lockdown for COVID-19." International journal of food sciences and nutrition vol. 73,1 (2022): 93-105. doi: https://doi.org/10.1080/09637486.2021.1921127
Censi L, Ruggeri S, Galfo M, Buonocore P, Roccaldo R. Eating behaviour, physical activity and lifestyle of Italian children during lockdown for COVID-19. Int J Food Sci Nutr. 2022 Feb;73(1):93-105. doi: 10.1080/09637486.2021.1921127. Epub 2021 May 12. PMID: 33975495.
Copy Download .nbib Format: NLM
Self-Oxygenation of Tissues Orchestrates Full-Thickness Vascularization of Living Implants.

Advanced functional materials

Farzin A, Hassan S, Teixeira LSM, Gurian M, Crispim JF, Manhas V, Carlier A, Bae H, Geris L, Noshadi I, Shin SR, Leijten J.
PMID: 34924912
Adv Funct Mater. 2021 Oct 14;31(42). doi: 10.1002/adfm.202100850. Epub 2021 Jul 06.

Bioengineering of tissues and organs has the potential to generate functional replacement organs. However, achieving the full-thickness vascularization that is required for long-term survival of living implants has remained a grand challenge, especially for clinically sized implants. During the...

Cite
Farzin A, Hassan S, Teixeira LSM, et al. Self-Oxygenation of Tissues Orchestrates Full-Thickness Vascularization of Living Implants. Adv Funct Mater. 2021;31(42)doi: 10.1002/adfm.202100850.
Farzin, A., Hassan, S., Teixeira, L. S. M., Gurian, M., Crispim, J. F., Manhas, V., Carlier, A., Bae, H., Geris, L., Noshadi, I., Shin, S. R., & Leijten, J. (2021). Self-Oxygenation of Tissues Orchestrates Full-Thickness Vascularization of Living Implants. Advanced functional materials, 31(42), . https://doi.org/10.1002/adfm.202100850
Farzin, Ali, et al. "Self-Oxygenation of Tissues Orchestrates Full-Thickness Vascularization of Living Implants." Advanced functional materials vol. 31,42 (2021). doi: https://doi.org/10.1002/adfm.202100850
Farzin A, Hassan S, Teixeira LSM, Gurian M, Crispim JF, Manhas V, Carlier A, Bae H, Geris L, Noshadi I, Shin SR, Leijten J. Self-Oxygenation of Tissues Orchestrates Full-Thickness Vascularization of Living Implants. Adv Funct Mater. 2021 Oct 14;31(42). doi: 10.1002/adfm.202100850. Epub 2021 Jul 06. PMID: 34924912; PMCID: PMC8680410.
Copy Download .nbib Format: NLM
Discharges With Triphasic Morphology as Marker of the Risk of Death in Acute Encephalopathy.

Clinical EEG and neuroscience

Merchán-Del-Hierro X, Persi G, Vulycher MC, Chicco C, Gatto EM, Pereira-de-Silva N.
PMID: 34609915
Clin EEG Neurosci. 2021 Oct 05;15500594211046702. doi: 10.1177/15500594211046702. Epub 2021 Oct 05.

No abstract available.

Cite
Merchán-Del-Hierro X, Persi G, Vulycher MC, et al. Discharges With Triphasic Morphology as Marker of the Risk of Death in Acute Encephalopathy. Clin EEG Neurosci. 2021;15500594211046702doi: 10.1177/15500594211046702.
Merchán-Del-Hierro, X., Persi, G., Vulycher, M. C., Chicco, C., Gatto, E. M., & Pereira-de-Silva, N. (2021). Discharges With Triphasic Morphology as Marker of the Risk of Death in Acute Encephalopathy. Clinical EEG and neuroscience, 15500594211046702. https://doi.org/10.1177/15500594211046702
Merchán-Del-Hierro, Xavier, et al. "Discharges With Triphasic Morphology as Marker of the Risk of Death in Acute Encephalopathy." Clinical EEG and neuroscience vol. (2021): 15500594211046702. doi: https://doi.org/10.1177/15500594211046702
Merchán-Del-Hierro X, Persi G, Vulycher MC, Chicco C, Gatto EM, Pereira-de-Silva N. Discharges With Triphasic Morphology as Marker of the Risk of Death in Acute Encephalopathy. Clin EEG Neurosci. 2021 Oct 05;15500594211046702. doi: 10.1177/15500594211046702. Epub 2021 Oct 05. PMID: 34609915.
Copy Download .nbib Format: NLM
Implication of a novel postoperative recovery protocol to increase day 1 discharge rate after anatomic lung resection.

Journal of thoracic disease

Schmid S, Kaafarani M, Baldini G, Amir A, Costescu F, Shafiepour D, Cools-Lartigue J, Najmeh S, Sirois C, Ferri L, Mulder D, Spicer J.
PMID: 34992820
J Thorac Dis. 2021 Nov;13(11):6399-6408. doi: 10.21037/jtd-21-965.

BACKGROUND: Chest-tube drainage and prolonged air leak after anatomic lung resection (ALR) continue to drive admission days for most programs employing minimal access techniques. The aim of the study was to evaluate the impact of a novel postoperative recovery...

Cite
Schmid S, Kaafarani M, Baldini G, et al. Implication of a novel postoperative recovery protocol to increase day 1 discharge rate after anatomic lung resection. J Thorac Dis. 2021;13(11):6399-6408doi: 10.21037/jtd-21-965.
Schmid, S., Kaafarani, M., Baldini, G., Amir, A., Costescu, F., Shafiepour, D., Cools-Lartigue, J., Najmeh, S., Sirois, C., Ferri, L., Mulder, D., & Spicer, J. (2021). Implication of a novel postoperative recovery protocol to increase day 1 discharge rate after anatomic lung resection. Journal of thoracic disease, 13(11), 6399-6408. https://doi.org/10.21037/jtd-21-965
Schmid, Severin, et al. "Implication of a novel postoperative recovery protocol to increase day 1 discharge rate after anatomic lung resection." Journal of thoracic disease vol. 13,11 (2021): 6399-6408. doi: https://doi.org/10.21037/jtd-21-965
Schmid S, Kaafarani M, Baldini G, Amir A, Costescu F, Shafiepour D, Cools-Lartigue J, Najmeh S, Sirois C, Ferri L, Mulder D, Spicer J. Implication of a novel postoperative recovery protocol to increase day 1 discharge rate after anatomic lung resection. J Thorac Dis. 2021 Nov;13(11):6399-6408. doi: 10.21037/jtd-21-965. PMID: 34992820; PMCID: PMC8662496.
Copy Download .nbib Format: NLM
Showing 217 to 227 of 227 entries